OQS
CYCN icon

Occudo Quantitative Strategies’s Cyclerion Therapeutics CYCN Stock Holding History

Occudo Quantitative Strategies’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,282
Closed -$78K – 787
2020
Q4 		$78K Buy
+1,282
New +$87.4K 0.02% 606

Other funds holding CYCN

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Occudo Quantitative Strategies's CYCN Position: Q1 2021 in Review

Occudo Quantitative Strategies sold out of Cyclerion Therapeutics (CYCN) in Q1 2021, closing a stake of 1,282 shares — an estimated $78K sold.

Occudo Quantitative Strategies first reported a position in CYCN in Q4 2020 and held it in 1 quarter. The position peaked at $78K in Q4 2020. 70 funds tracked by Wall St. Rank hold CYCN as of Q1 2021.

  • Occudo Quantitative Strategies reported no remaining Cyclerion Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 1,282 Cyclerion Therapeutics shares in Q1 2021, an estimated $78K.
  • Occudo Quantitative Strategies first reported a position in Cyclerion Therapeutics in Q4 2020 and held it in 1 quarter.
  • Occudo Quantitative Strategies's Cyclerion Therapeutics position peaked at $78K in Q4 2020.
  • 70 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q1 2021.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2021, filed 14 May 2021.